Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: March 2024

Vision Marine Technologies Inc. (NASDAQ: VMAR) Unveils New E-Boat Model, Names New CFO in Preparation for Industry Growth

As the electric boat sector is projected to double in value in the next few years, companies operating in the industry are positioning themselves to meet — and even exceed — the expectations this growth could create. For example, Vision … Continue reading

Posted in Vision Marine Technologies Inc. VMAR | Leave a comment

MissionIRNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Expanding Operations Within Agricultural Sectors

SenesTech (NASDAQ: SNES), a rodent pest control enterprise, has begun to establish a global reach for its innovative Birth Control for Rats(TM) products. “The company is expanding its operations within agricultural sectors where rodent predation may otherwise have costly effects … Continue reading

Posted in SenesTech Inc. SNES | Leave a comment

MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $6.5M Registered Direct Offering

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. The company today announced its entry into definitive agreements for the sale and issuance of 1,542,112 shares of its common … Continue reading

Posted in Genprex Inc. GNPX | Leave a comment

MissionIRNewsBreaks – Clene Inc.’s (NASDAQ: CLNN) Work in Nanotechnology Highlighted in ‘First in Human’ Podcast

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, was featured in a recent episode of First in Human, a biotech-focused podcast featuring interviews with industry leaders and investors to learn about their journeys to in-human clinical trials. Hosted by Vial … Continue reading

Posted in Clene Inc. CLNN | Leave a comment

Correlate Energy Corp. (CIPI) Targets the U.S. Zero Operating Emissions Market

Correlate Energy (OTCQB: CIPI), a publicly traded company positioned to capitalize on America’s move toward efficient energy sourcing and use, is aware of the growing pressure for buildings to become more energy efficient. This follows the federal government’s aggressive push … Continue reading

Posted in Correlate Infrastructure Partners Inc. CIPI | Leave a comment

SenesTech Inc. (NASDAQ: SNES) Closes Multiple Global Distribution Deals; Eyes 2024 as its Best Year Yet

SenesTech (NASDAQ: SNES), a rodent fertility control solutions provider, and the inventor of the only EPA-registered contraceptive for male and female rats, is pleased to announce multiple distribution deals globally in what marks a huge milestone for the company, just … Continue reading

Posted in SenesTech Inc. SNES | Leave a comment

MissionIRNewsBreaks — D-Wave Quantum Inc. (NYSE: QBTS) Schedules Q4, FY 2023 Earnings Call

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, plans to release its financial results for the fourth quarter and fiscal year 2023 for the period … Continue reading

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Welcomes Proven Commercialization Leader to Its Board of Directors

With a fervent commitment to developing and commercializing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system, clinical-stage biopharmaceutical company CNS Pharmaceuticals (NASDAQ: CNSP) continues to advance its … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Zoned Properties Inc. (ZDPY) Seeks to Bridge the Real Estate Shortage for the U.S. Cannabis Retail Operators

In 2021, New York state officially legalized the usage of marijuana for recreational purposes; nevertheless, and nearly three years on from the landmark decision, cannabis supply for retail consumers remains painfully constrained. In April 2023, plans to build out a … Continue reading

Posted in Zoned Properties Inc. ZDPY | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks Huge 2024 Milestone with FDA Clearance for its Planned U.S. Phase 1b Hypertension Clinical Trial

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced that the U.S. Food and Drug Administration (“FDA”) has given it the requisite clearance to proceed with its planned U.S. Phase 1b hypertension clinical trial. This follows … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment